APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma Meeting Abstract
| Authors: | Tempero, M. A.; Reni, M.; Riess, H.; Pelzer, U.; O'Reilly, E. M.; Winter, J. M.; Oh, D. Y.; Li, C. P.; Tortora, G.; Chang, H. M.; Lopez, C. D.; Tabernero, J.; Van Cutsem, E.; Philip, P. A.; Goldstein, D.; Berlin, J.; Ferrara, S.; Li, M.; Lu, B. D.; Biankin, A. |
| Abstract Title: | APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 222s |
| Language: | English |
| ACCESSION: | WOS:000487345805191 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.4000 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4000 -- Source: Wos |
